Aberrant CpG‐methylation affects genes expression predicting survival in lung adenocarcinoma
Open Access
- 23 October 2018
- journal article
- research article
- Published by Wiley in Cancer Medicine
- Vol. 7 (11) , 5716-5726
Abstract
Lung adenocarcinoma (LUAD) is a common diagnosed disease with high‐mortality rate, and its prognostic implications are under discovered. DNA methylation aberrations are not only an important event for dysregulation of gene expression during tumorigenesis but also a revolution in epigenetics by identifying key prognostic biomarkers for multiple cancers. In this study, we analyzed methylation status of 485 578 CpG sites and RNA‐seq transcriptomes of 20 532 genes for 1095 LUAD samples in TCGA database. The association between DNA methylation and the prognostic value of the corresponding gene expression was identified as well. In total, ten aberrantly methylated and dysregulated genes (AURKA, BLK, CNTN2, HMGA1, PTTG1, TNS4, DAPK2, MFSD2A, THSD1, and WNT7A) were highlighted which were significantly correlated with overall survival of 492 LUAD patients, which were all reported as tumor‐associated genes in other various cancers and worthy of further investigated and might be used as therapeutic targets for LUAD. Together, methylation aberrances regulate gene expression level during tumorigenesis and influence prognosis of LUAD patients. Integrating knowledge of epigenetics and expression of genes can be useful for an in‐depth understanding of cancer mechanism and for the eventual purpose of precisely prognostic and therapeutic target verification.Keywords
This publication has 37 references indexed in Scilit:
- Functions of DNA methylation: islands, start sites, gene bodies and beyondNature Reviews Genetics, 2012
- MS4A1 Dysregulation in Asbestos-Related Lung Squamous Cell Carcinoma Is Due to CD20 Stromal Lymphocyte ExpressionPLOS ONE, 2012
- An integrative analysis of DNA methylation and RNA-Seq data for human heart, kidney and liverBMC Systems Biology, 2011
- DNA Methylation: Superior or Subordinate in the Epigenetic Hierarchy?Genes & Cancer, 2011
- MFSD2A is a novel lung tumor suppressor gene modulating cell cycle and matrix attachmentMolecular Cancer, 2010
- Dna Hypomethylation In Cancer CellsEpigenomics, 2009
- Monochromosome Transfer and Microarray Analysis Identify a Critical Tumor-Suppressive Region Mapping to Chromosome 13q14 and THSD1 in Esophageal CarcinomaMolecular Cancer Research, 2008
- Cancer epigenomics: DNA methylomes and histone-modification mapsNature Reviews Genetics, 2007
- Epigenetic diagnostics of cancer — the application of DNA methylation markersJournal of Applied Genetics, 2006
- Smoking and cancer‐related gene expression in bronchial epithelium and non‐small‐cell lung cancersThe Journal of Pathology, 2006